Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monosialotetrahexosylganglioside sodium for acute ischemic stroke
CTR20201746Phase 4Completed
- Sponsor
- Beijing Sciecure Pharmaceutical
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of edaravone in ischemic stroke, sponsored by Beijing Sciecure Pharmaceutical. Started Aug 2020; status: completed.
02
Drugs
edaravone
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20201746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201746.